ZBIO - Zenas Bio Qarzning balans kapitallashuviga nisbati
Zenas Biopharma Inc (ZBIO) o'zining tadqiqot va ishlanmalar (R&D) faoliyatini kamyob autoimmun kasalliklarga qarshi kurashish uchun noyob bifunksional antitanachalar yaratishga qaratgan. Biznes uzoq muddatli talab va yuqori marjalarni ta'minlaydigan inqilobiy monoklonal birikmalarning ishlab chiqilishiga tayanadi. Joriy ko'rsatkich 1.61 hisoblanadi. GURU.Markets platformasidagi aksiyalar narxining tebranishlari kelajakdagi foydasi klinik sinovlar natijalari va yangi molekulalarning afzalliklariga bog'liq bo'lgan biotexnologiya startapining dinamikasini aks ettiradi.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_ZBIO_-_Zenas-Biopharma-Inc_-_Debt-to-Net-Assets-Ratio "Zenas Biopharma Inc - ZBIO Qarzning balans kapitallashuviga nisbati (davr: 14.09.2024 - 29.10.2026) | 👁️GURU.Markets👁️")
Zenas Bio (ZBIO) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Zenas Biopharma Inc|ZBIO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Zenas Biopharma, Inc.|ZBIO - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati Zenas Corp|ZBIO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Zenas Biopharma
Kompaniyaning jamlanma tahliliyoti:Zenas Biopharma Inc (ZBIO)
Zenas Biopharma Inc (ZBIO) avtoimmun patologiyalarni davolash uchun immunologik dori vositalarining yuqori texnologik ekotizimini ishlab chiqmoqda, bu esa sezilarli kapital xarajatlarini talab qiladi. Ushbu ko'rsatkich qarz mablag'larining hajmini o'z kapitaliga solishtirib, moliyaviy leverajni va biznesning kreditorlarga bog'liqlik darajasini o'lchaydi, bu esa ushbu umumiy qarzdorlikning kapitalga nisbati grafigi orqali kapital xarajatlarining oshish xavfini va kompaniyaning bozor tebranishlariga chidamliligini baholash imkonini beradi.
Zenas Biopharma Inc kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|IMNM - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Gossamer Corp|KALV - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar SEPN|PVLA (pieris.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Savara (SVRA)|Qarzning balans qiymatiga nisbati Rigel Pharma|Balans kapitallashuviga qarzlar ANAB|Balans kapitallashuviga qarzlar ATXS (Astria Corp)|Qarzning balans kapitallashuviga nisbati ENGN|RAPT - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Aerovate (JBIO)|ACRS - Qarzning sof aktivlarga nisbati|Kyverna (KYTX) - Balans kapitallashuviga qarzlar|Tiziana Life Sciences, Ltd. (TLSA) - Qarzning balans kapitallashuviga nisbati|CABA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar VTYX|Theratechnologies - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar AVTX (Avalo Therapeutics, Inc.)|Eledon (ELDN) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Agenus, Inc AGEN|Balans kapitallashuviga qarzlar Climb Bio Inc (CLYM)|ZURA - Qarzning sof aktivlarga nisbati|ATYR: Balans kapitallashuviga qarzlar|ADAG (Adagene Inc.) - Balans kapitallashuviga qarzlar|IMA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati STTK|Qarzning balans kapitallashuviga nisbati EQ (Equillium, Inc.)|Qarzning balans qiymatiga nisbati connectbiopharm.com (CNTB)|Balans kapitallashuviga qarzlar IMUX (Immunic)|ATRA - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati InflaRx GmbH (IFRX)|XFOR - Qarzning sof aktivlarga nisbati|adicetbio.com - Balans kapitallashuviga qarzlar|CELU (Celularity) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati INmune Bio (INMB)|Qarzning balans qiymatiga nisbati Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc SABS|Akari Therapeutics (AKTX) - Qarzning balans qiymatiga nisbati|Qarzlarning balans kapitallashuviga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Balans kapitallashuviga qarzlar|GOVX - Qarzning balans kapitallashuviga nisbati|Edesa - Balans kapitallashuviga qarzlar|IBIO (iBio Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CARM (Carisma Therapeutics Inc)|Balans qiymatiga qarzlar XTLB|BOLT - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati hcwbiologics.com (HCWB)|Balans kapitallashuviga qarzlar Aptevo Therapeutics Inc.|Qarzning sof aktivlarga nisbati AIM ImmunoTech, Inc. AIM|Aditxt Corp - Balans kapitallashuviga qarzlar|GRI: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati XORTX Therapeutics XRTX|HIND (Vyome Holdings Inc.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati REVB|Qarzning balans qiymatiga nisbati Indaptus Corp|Balans kapitallashuviga qarzlar SCNI|Balans kapitallashuviga qarzlar calcimedica.com CALI|Qarzning balans qiymatiga nisbati Affimed N.V.|Qarzning sof aktivlarga nisbati Allakos Inc ALLK|Balans kapitallashuviga qarzlar HOOK (HOOKIPA)|IGMS: Sof aktivlarga qarzlar|ITOS (iTeos Therapeutics) - Qarzning balans kapitallashuviga nisbati|OCEA (oceanbiomedical.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati TCBP|Qarzning balans qiymatiga nisbati Third Harmonic Bio Inc. (THRD)